These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7540370)

  • 1. Osteopontin overview.
    Rodan GA
    Ann N Y Acad Sci; 1995 Apr; 760():1-5. PubMed ID: 7540370
    [No Abstract]   [Full Text] [Related]  

  • 2. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity.
    Hruska KA; Rolnick F; Huskey M; Alvarez U; Cheresh D
    Ann N Y Acad Sci; 1995 Apr; 760():151-65. PubMed ID: 7540372
    [No Abstract]   [Full Text] [Related]  

  • 3. Roles of osteopontin in bone remodeling.
    Heinegård D; Andersson G; Reinholt FP
    Ann N Y Acad Sci; 1995 Apr; 760():213-22. PubMed ID: 7540374
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of osteopontin with osteoclast integrins.
    Horton MA; Nesbit MA; Helfrich MH
    Ann N Y Acad Sci; 1995 Apr; 760():190-200. PubMed ID: 7540373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion.
    Senger DR; Brown LF; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
    Ann N Y Acad Sci; 1995 Apr; 760():83-100. PubMed ID: 7540380
    [No Abstract]   [Full Text] [Related]  

  • 6. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.
    Liaw L; Skinner MP; Raines EW; Ross R; Cheresh DA; Schwartz SM; Giachelli CM
    J Clin Invest; 1995 Feb; 95(2):713-24. PubMed ID: 7532190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin expression in cardiovascular diseases.
    Giachelli CM; Liaw L; Murry CE; Schwartz SM; Almeida M
    Ann N Y Acad Sci; 1995 Apr; 760():109-26. PubMed ID: 7785890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming obstacles to metastasis--defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells.
    Denhardt DT; Chambers AF
    J Cell Biochem; 1994 Sep; 56(1):48-51. PubMed ID: 7528752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional domains of osteopontin.
    Butler WT
    Ann N Y Acad Sci; 1995 Apr; 760():6-11. PubMed ID: 7785926
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitronectin and its receptors.
    Felding-Habermann B; Cheresh DA
    Curr Opin Cell Biol; 1993 Oct; 5(5):864-8. PubMed ID: 7694604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interaction between integrins and recombinant human osteopontin.
    Hu DD; Hoyer JR; Smith JW
    Ann N Y Acad Sci; 1995 Apr; 760():312-4. PubMed ID: 7540375
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteopontin-induced modifications of cellular functions.
    Denhardt DT; Lopez CA; Rollo EE; Hwang SM; An XR; Walther SE
    Ann N Y Acad Sci; 1995 Apr; 760():127-42. PubMed ID: 7540371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of a signal transduction pathway by osteopontin.
    Lopez CA; Davis RL; Mou K; Denhardt DT
    Ann N Y Acad Sci; 1995 Apr; 760():324-6. PubMed ID: 7540377
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions.
    Shankar G; Gadek TR; Burdick DJ; Davison I; Mason WT; Horton MA
    Exp Cell Res; 1995 Aug; 219(2):364-71. PubMed ID: 7543851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.
    Lehmann M; Rabenandrasana C; Tamura R; Lissitzky JC; Quaranta V; Pichon J; Marvaldi J
    Cancer Res; 1994 Apr; 54(8):2102-7. PubMed ID: 7513610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mutagenesis of the RGD sequence of recombinant osteopontin causes it to lose its cell adhesion ability.
    McFarland RJ; Garza S; Butler WT; Höök M
    Ann N Y Acad Sci; 1995 Apr; 760():327-31. PubMed ID: 7785910
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteopontin: a ligand for the alpha v beta 3 integrin of the osteoclast clear zone in osteopetrotic (ia/ia) rats.
    Hultenby K; Reinholt FP; Heinegård D; Andersson G; Marks SC
    Ann N Y Acad Sci; 1995 Apr; 760():315-8. PubMed ID: 7540376
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteopontin--a possible anchor of osteoclasts to bone.
    Reinholt FP; Hultenby K; Oldberg A; Heinegård D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4473-5. PubMed ID: 1693772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity.
    Hruska KA; Rolnick F; Huskey M; Alvarez U; Cheresh D
    Endocrinology; 1995 Jul; 136(7):2984-92. PubMed ID: 7540546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation.
    Lai CF; Cheng SL
    J Bone Miner Res; 2005 Feb; 20(2):330-40. PubMed ID: 15647827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.